Ki-67 is a Valuable Prognostic Factor in Gliomas: Evidence from a Systematic Review and Meta-analysis |
Chen, Wen-Jie
(Department of Pathology, First Affiliated Hospital of Guangxi Medical University)
He, De-Shen (Department of Neurology, Seventh Affiliated Hospital of Guangxi Medical University, Wuzhou Worker Hospital) Tang, Rui-Xue (Department of Pathology, First Affiliated Hospital of Guangxi Medical University) Ren, Fang-Hui (Department of Pathology, First Affiliated Hospital of Guangxi Medical University) Chen, Gang (Department of Pathology, First Affiliated Hospital of Guangxi Medical University) |
1 | Abd El Atti RM, Abou Gabal HH, Osman WM, et al (2013). Insights into the prognostic value of DJ-1 and MIB-1 in astrocytic tumors. Diagn Pathol, 8, 126. DOI |
2 | Armstrong TS, Vera-Bolanos E, Bekele BN, et al (2010). Adult ependymal tumors: prognosis and the M.D. anderson cancer center experience. Neuro Oncol, 12, 862-70. DOI |
3 | Bowers DC (2003). Study of the MIB-1 labeling index as a predictor of tumor progression in pilocytic astrocytomas in children and adolescents. J Clin Oncol, 21, 2968-73. DOI |
4 | Bredel M, Piribauer M, Marosi C, et al (2002). High expression of DNA topoisomerase and Ki-67 antigen is associated with prolonged survival in glioblastoma patients. European J Cancer, 38, 1343-7. DOI |
5 | Chiang MDH, Ting ML-T, Hsu MDMHAC-Y, et al (2003). MIB-1 and DNA topoisomerase IIa could be helpful for predicting long-term survival of patients with glioblastoma. Am J Clin Pathol, 119, 715-22. DOI |
6 | Coons SW, Johnson PC, Pearl DK (1997). The prognostic significance of Ki-67 labeling indices for oligodendrogliomas. Neurosurgery, 41, 878-85. DOI |
7 | Dang YW, Zeng J, He RQ, et al (2014). Effects of miR-152 on cell growth inhibition, motility suppression and apoptosis induction in hepatocellular carcinoma cells. Asian Pac J Cancer Prev, 15, 4969-76. DOI |
8 | Dehghani F, Schachenmayr W, Laun A, et al (1998). Prognostic implication of histopathological, immunohistochemical and clinical features of oligodendrogliomas: a study of 89 cases. Acta Neuropathologica, 95, 493-504. DOI |
9 | Donato V, Papaleo A, Castrichino A, et al (2007). Prognostic implication of clinical and pathologic features in patients with glioblastoma multiforme treated with concomitant radiation plus temozolomide. Tumori, 93, 248. |
10 | Ellison DW, Steart PV, Bateman AC, et al (1995). Prognostic indicators in a range of astrocytic tumours: an immunohistochemical study with Ki-67 and p53 antibodies. J Neurol Neurosurg Psychiatry, 59, 413-9. DOI |
11 | Fakhrjou A, Dastranj-Tabrizi A, Ghojazadeh M, et al (2013). Diagnostic value of protein Ki67 (MIB-1) in atypical Pap smears of postmenopausal women. Asian Pac J Cancer Prev, 14, 4815-8. DOI ScienceOn |
12 | Figarella-Branger D, Civatte M, Bouvier-Labit C, et al (2000). Prognostic factors in intracranial ependymomas in children. J Neurosurg, 93, 605-13. DOI |
13 | Habberstad AH, Gulati S, Torp SH (2011). Evaluation of the proliferation markers Ki-67/MIB-1, mitosin, survivin, pHH3, and DNA topoisomerase IIa in human anaplastic astrocytomas-an immunohistochemical study. Diagn Pathol, 6, 43. DOI |
14 | Haroon S, Hashmi AA, Khurshid A, et al (2013). Ki67 index in breast cancer: correlation with other prognostic markers and potential in pakistani patients. Asian Pac J Cancer Prev, 14, 4353-8. DOI |
15 | Heegaard S, Sommer HM, Broholm H, et al (1995). Proliferating cell nuclear antigen and Ki-67 immunohistochemistry of oligodendrogliomas with special reference to prognosis. Cancer, 76, 1809-13. DOI |
16 | Hernandez-Pedro NY, Rangel-Lopez E, Magana-Maldonado R, et al (2013). Application of nanoparticles on diagnosis and therapy in gliomas. Biomed Res Int, 2013, 351031. |
17 | Higgins J, Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Statistics in medicine, 21, 1539-58. DOI |
18 | Ho DM-T, Hsu C-Y, Wong T-T, et al (2001). A clinicopathologic study of 81 patients with ependymomas and proposal of diagnostic criteria for anaplastic ependymoma. J Neuro-Oncol, 54, 77-85. DOI |
19 | Huang S, Chen G (2014). Overexpression of DcR3 and its significance on tumor cell differentiation and proliferation in glioma. Scientific World J, 2014, 605236. |
20 | Hu X, Miao W, Zou Y, et al (2013). Expression of p53, epidermal growth factor receptor, Ki-67 and O6-methylguanine-DNA methyltransferase in human gliomas. Oncol Letters, 6, 130-4. |
21 | Huang T, Jin X, He L, et al (2013). Role of podocalyxin in astrocytoma: clinicopathological and evidence. Oncol Lett, 6, 1390-6. |
22 | Jaros E, Perry R, Adam L, et al (1992). Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours. Br J Cancer, 66, 373. DOI |
23 | Kanamori M, Kumabe T, Sonoda Y, et al (2008). Predictive factors for overall and progression-free survival, and dissemination in oligodendroglial tumors. J Neuro-Oncol, 93, 219-28. |
24 | Kleinschmidt-DeMasters BK, Meltesen L, McGavran L, et al (2006). Characterization of glioblastomas in young adults. Brain Pathology, 16, 273-86. DOI |
25 | Kohler BA, Ward E, McCarthy BJ, et al (2011). Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst, 103, 714-36 DOI |
26 | Kouri FM, Jensen SA, Stegh AH (2012). The role of Bcl-2 family proteins in therapy responses of malignant astrocytic gliomas: Bcl2L12 and beyond. Scientific World J, 2012, 838916. |
27 | Kros JM, Hop WC, Godschalk JJ, et al (1996). Prognostic value of the proliferation-related antigen Ki-67 in oligodendrogliomas. Cancer, 78, 1107-13. DOI |
28 | Lau J, Ioannidis JP, Schmid CH (1997). Quantitative synthesis in systematic reviews. Ann Intl Med, 127, 820-6. DOI |
29 | Kuo LT, Kuo KT, Lee MJ, et al (2009). Correlation among pathology, genetic and epigenetic profiles, and clinical outcome in oligodendroglial tumors. Int J Cancer, 124, 2872-9. DOI |
30 | Laks DR, Masterman-Smith M, Visnyei K, et al (2009). Neurosphere formation is an independent predictor of clinical outcome in malignant glioma. Stem Cells, 27, 980-7. DOI |
31 | Li S-W, Qiu X-G, Chen B-S, et al (2009). Prognostic factors influencing clinical outcomes of glioblastoma multiforme. Chin Med J, 122, 1245-9. |
32 | Liu Y, Tang K, Yan W, et al (2013). Identifying Ki-67 specific miRNA-mRNA interactions in malignant astrocytomas. Neuroscience Letters, 546, 36-41. DOI |
33 | Margraf LR, Gargan L, Butt Y, et al (2011). Proliferative and metabolic markers in incompletely excised pediatric pilocytic astrocytomas-an assessment of 3 new variables in predicting clinical outcome. Neuro Oncol, 13, 767-74. DOI |
34 | McKeever PE, Strawderman MS, Yamini B, et al (1998). MIB- 1 proliferation index predicts survival among patients with grade II astrocytoma. J Neuropathol Exp Neurol, 57, 931-6. DOI |
35 | Montine TJ, Vandersteenhoven JJ, Aguzzi A, et al (1994). Prognostic significance of Ki-67 proliferation index in supratentorial fibrillary astrocytic neoplasms. Neurosurgery, 34, 674-9. DOI |
36 | Nabika S, Kiya K, Satoh H, et al (2010). Prognostic significance of expression patterns of EGFR family, p21 and p27 in high-grade astrocytoma. Hiroshima J Med Sci, 59, 65-70. |
37 | Nazarenko I, Hede SM, He X, et al (2012). PDGF and PDGF receptors in glioma. Ups J Med Sci, 117, 99-112. DOI |
38 | Park KJ, Kang SH, Park DH, et al (2012). Usefulness of thallium-201 SPECT for prediction of early progression in low-grade astrocytomas diagnosed by stereotactic biopsy. Clin Neurol Neurosurg, 114, 223-9. DOI |
39 | Neder L, Colli B, Machado H, et al (2003). MIB-1 labeling index in astrocytic tumors-a clinicopathologic study. Clin Neuropathol, 23, 262-70. DOI |
40 | Okita Y, Narita Y, Miyakita Y, et al (2012). Pathological findings and prognostic factors in recurrent glioblastomas. Brain Tumor Pathol, 29, 192-200. DOI |
41 | Parmar MK, Torri V, Stewart L (1998). Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med, 17, 2815-34. DOI |
42 | Phi JH, Wang KC, Park SH, et al (2012). Pediatric infratentorial ependymoma: prognostic significance of anaplastic histology. J Neurooncol, 106, 619-26. DOI |
43 | Pollack IF, Campbell JW, Hamilton RL, et al (1997). Proliferation index as a predictor of prognosis in malignant gliomas of childhood. Cancer, 79, 849-56. DOI |
44 | Pollack IF, Hamilton RL, Burnham J, et al (2002). Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort. Neurosurgery, 50, 1238-45. |
45 | Preusser M, Hoeftberger R, Woehrer A, et al (2012). Prognostic value of Ki67 index in anaplastic oligodendroglial tumours--a translational study of the European organization for research and treatment of cancer brain tumor group. Histopathology, 60, 885-94. DOI |
46 | Preusser M, Wolfsberger S, Czech T, et al (2005). Survivin expression in intracranial ependymomas and its correlation with tumor cell proliferation and patient outcome. Am J Clin Pathol, 124, 543-9. DOI |
47 | Rodriguez-Pereira C, Suarez-Penaranda J, Vazquez-Salvado M, et al (2000). Value of MIB-1 labelling index (LI) in gliomas and its correlation with other prognostic factors. A clinicopathologic study. J Neurosurg Sci, 44, 203-9; discussion 9-10. |
48 | Qiang J, Wei Z, Xiao-Guang Q, et al (2011). Gene expression profiling reveals Ki-67 associated proliferation signature in human glioblastoma. Chinese Med J Beijing, 124, 2584. |
49 | Reavey-Cantwell JF, Haroun RI, Zahurak M, et al (2001). The prognostic value of tumor markers in patients with glioblastoma multiforme: analysis of 32 patients and review of the literature. J Neuro-Oncol, 55, 195-204. DOI |
50 | Ritter AM, Hess KR, McLendon RE, et al (1998). Ependymomas: MIB-1 proliferation index and survival. J Neurooncol, 40, 51-7. DOI |
51 | Shen C, Yang L, Yuan X (2011). Endothelin B receptor expression in human astrocytoma: association with clinicopathological variables and survival outcomes. Int J Neurosci, 121, 626-31. DOI |
52 | Tadbir AA, Pardis S, Ashkavandi ZJ, et al (2012). Expression of Ki67 and CD105 as proliferation and angiogenesis markers in salivary gland tumors. Asian Pac J Cancer Prev, 13, 5155-9. DOI ScienceOn |
53 | Tian B, Zhang Y, Zhang J (2014). Periostin is a new potential prognostic biomarker for glioma. Tumour Biol, 35, 5877-83. DOI |
54 | Torp S, Helseth E, Dalen A, et al (1992). Relationships between Ki-67 labelling index, amplification of the epidermal growth factor receptor gene, and prognosis in human glioblastomas. Acta Neurochirurgica, 117, 182-6. DOI |
55 | Tove L-L, Hansson HA, Stein S, et al (2012). Prognostic value of histological features in diffuse astrocytomas WHO grade II. Interl J Clin Experimental Pathol, 5, 152. |
56 | Wessels PH, Hopman AH, Kubat B, et al (2003). Proliferation and aneusomy predict survival of young patients with astrocytoma grade II. Br J Cancer, 89, 128-34. DOI |
57 | Uematsu M, Ohsawa I, Aokage T, et al (2005). Prognostic significance of the immunohistochemical index of survivin in glioma: a comparative study with the MIB-1 index. J Neurooncol, 72, 231-8. DOI |
58 | Watanabe Y, Yamasaki F, Kajiwara Y, et al (2010). Expression of phosphoprotein enriched in astrocytes 15 kDa (PEA-15) in astrocytic tumors: a novel approach of correlating malignancy grade and prognosis. J Neurooncol, 100, 449-57. DOI |
59 | Wen PY, Kesari S (2008). Malignant gliomas in adults. New England J Med, 359, 492-507. DOI |
60 | Westermark B (2012). Glioblastoma-a moving target. Ups J Med Sci, 117, 251-6. DOI |
61 | Yang P, Wang Y, Peng X, et al (2013). Management and survival rates in patients with glioma in China (2004-2010): a retrospective study from a single-institution. J Neurooncol, 113, 259-66. DOI |
62 | Yoshida Y, Nakada M, Harada T, et al (2010). The expression level of sphingosine-1-phosphate receptor type 1 is related to MIB-1 labeling index and predicts survival of glioblastoma patients. J Neurooncol, 98, 41-7. DOI |
63 | Yue Q, Zhang X, Ye HX, et al (2014). The prognostic value of Foxp3+ tumor-infiltrating lymphocytes in patients with glioblastoma. J Neurooncol, 116, 251-9. DOI |
64 | Zamecnik J, Snuderl M, Eckschlager T, et al (2003). Pediatric intracranial ependymomas: prognostic relevance of histological, immunohistochemical, and flow cytometric factors. Modern Pathol, 16, 980-91. DOI |
65 | Zhong D, Li X, Zhang G (2001). Multivariate analysis of the parameters related to prognosis of astrocytoma. Zhonghua Bing Li Xue Za Zhi Chinese J Pathol, 30, 345-9. |
66 | Zawrocki A, Izycka-Swieszewska E, Papierz W, et al (2011). Analysis of the prognostic significance of selected morphological and immunohistochemical markers in ependymomas, with literature review. Folia Neuropathol, 49, 94-102. |
67 | Zhao S, Wu J, Wang C, et al (2013). Intraoperative fluorescenceguided resection of high-grade malignant gliomas using 5-aminolevulinic acid-induced porphyrins: a systematic review and meta-analysis of prospective studies. PLoS One, 8, e63682. DOI |